Article
Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice.
The Journal of clinical investigation - 1 Aug 2011
Wang Hongwei, Venkatesh Madhukumar, Li Hao, Goetz Regina, Mukherjee Subhajit, Biswas Arunima, Zhu Liang, Kaubisch Andreas, Wang Lei, Pullman James, Whitney Kathleen, Kuro-o Makoto, Roig Andres I, Shay Jerry W, Mohammadi Moosa, Mani Sridhar
Abstract excerpt
The nuclear receptor pregnane X receptor (PXR) is activated by a range of xenochemicals, including chemotherapeutic drugs, and has been suggested to play a role in the development of tumor cell resistance to anticancer drugs. PXR also has been implicated as a regulator of the growth and apoptosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
